Tomoaki Hasui

Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.

Hideki Matsui, Shoji Fukumoto, Midori Ono, 2011, Journal of medicinal chemistry.

Development of a series of novel carbon-11 labeled PDE10A inhibitors.

Christer Halldin, Vladimir Stepanov, Ryuji Nakao, 2015, Journal of labelled compounds & radiopharmaceuticals.

Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.

Christer Halldin, Vladimir Stepanov, Akihiro Takano, 2015, Nuclear medicine and biology.

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.

Atsushi Mizukami, Jun Fujimoto, Koji Fuji, 2014, Bioorganic & medicinal chemistry.

Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists.

Atsushi Mizukami, Hideki Matsui, Shoji Fukumoto, 2013, Bioorganic & medicinal chemistry.